Connect with us
More and more people are getting cancer. In Germany alone, doctors diagnose around half a million new cancer patients every year. But science is also making...
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...
